San Francisco, 16 January 2019: The Report In Vivo CRO Market Analysis, by Type (Rodent, Non-Rodent), by Indication
(Autoimmune/ Inflammatory Conditions, Pain Management, Oncology, CNS
Conditions, Diabetes, Obesity), And Segment Forecasts To 2024
The global in vivo CRO market is expected to reach USD 4.9 billion by 2024, according
to a new report by Grand View Research, Inc. Economic efficiency and focus on
core competencies by pharmaceutical giants are anticipated to be the primary
market promoters.
The use of Contract Research Organization
(CRO) services helps manufacturers/ sponsors to provide complete attention on
the production capacity and at enhancing their in-house processes.
The availability of the vast array of
services from drug discovery to post-marketing surveillance has further
simplified the work for mid-size and small-scale pharmaceutical and
biotechnological organizations by providing them the option to outsource what
they think is beyond their core expertise.
North America held a substantial share of 49.8% in the In-Vivo CRO
market in 2015. This can be attributed to the presence of technologically
advanced CROs present in this region. The U.S. has the highest per capita
healthcare spending and availability of funding and grants from government
organizations such as the National Institute of Health (NIH) fosters research
activities.
For instance, approximately 47.0% of
research funded by the NIH involves experimentation on animals, and in 2012,
the NIH budgeted nearly USD 30.0 billion for R&D. The trend for reducing
the R&D cost level is most common in major life sciences companies.
Clinical trial sponsors are facing huge pressure owing to the increasing
complexity in the research methodology to reduce time and cost.
Asia Pacific is projected to exhibit lucrative growth
over the forecast period. The presence of untapped opportunities, constantly
improving healthcare infrastructure, economic development, and huge patient
base are some factors responsible for the rapid growth. This region also ranks
on top in ease of doing business. Moreover, with the availability of qualified
labor and other resources, Asia Pacific would be the key destination for In-Vivo CRO
projects over the forecast period.
Access
Research Report of In Vivo CRO Market@ www.grandviewresearch.com/industry-analysis/in-vivo-cro-market
Further Key Findings From the Study Suggest:
· The rodent based In-Vivo CRO segment is
likely to dominate the market throughout the forecast period. Mice and rat
are the predominantly used animals for preclinical evaluation and together are
expected to hold above 70.0% of the market share over the forecast period.
· North America dominated In-Vivo CRO
market in 2015 with the major contributions from the U.S. Presence of ample
funding in this region has boosted the research activities.
· Asia Pacific is the fastest growing market
owing to many developed countries investing in Asia Pacific regions and owing
to the various amendments made by the regulatory market to change the clinical
trials evaluation standards according to the global platform.
· Some key players are Quintiles, Charles
River Laboratories, Covance, Parexel, ICON Plc.
· The In-Vivo CRO market has
been segmented into autoimmune/inflammation conditions, pain management,
oncology, CNS conditions, diabetes, obesity, and others. As of 2015, majority
of the work is being done in the field of oncology, which contributes to about
28.0% of the market share. This share is attributed to the rising cases of
cancer across the globe and the increasing focus of pharmaceutical players on
introducing novel drug treatments with fewer side-effects.
Browse more reports of
this category by Grand View Research at: www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented In-Vivo CRO
market on the basis of types, indication, and region.
Global In-vivo CRO Type Outlook
(Revenue, USD Million, 2013 - 2024)
·
Rodent Based
·
Non Rodent Based
Global In-vivo CRO Indication Outlook
(Revenue, USD Million, 2013 - 2024)
·
Autoimmune
·
Pain Management
·
Oncology
·
CNS Conditions
·
Diabetes
·
Obesity
·
Others
In-Vivo CRO Regional Outlook (Revenue, USD
Million, 2013 - 2024)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
MEA
Access Press Release of
In Vivo CRO Market@ www.grandviewresearch.com/press-release/global-in-vivo-cro-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com